NCT06632730Completed
Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain
Therapeutic Management and Current Situation Related to the Use of Resources and Costs of Spinal Muscular Atrophy (SMA) in Spain: A Retrospective, Multicenter Analysis Based on Medical Record Review. TREaSURE Study
Source: ClinicalTrials.gov · Last updated 9 Oct 2024
Brief summary (registry, in English)
An observational, retrospective, cross-sectional, multicenter study. Real-world data were obtained from medical records of Spanish public hospitals (9 hospitals).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 69 (actual)
- First submitted
- 7 Oct 2024
- Start date
- 5 Jul 2023
- Primary completion date
- 20 Nov 2023
- Lead sponsor
- Novartis
- Diseases
- Spinal muscular atrophy
- NCT number
- NCT06632730
What you commit to
- Study type: Observational
- Participants enrolled: 69
- From 5 Jul 2023 to the primary completion date, 20 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who participated in an experimental design study except for those in the long-term follow-up period, during the observation period.
Who the study is looking for
- Patients diagnosed with SMA type I or SMA type II.
- Patients with medical records available in the hospital.
- Patients diagnosed with SMA type I or SMA type II after 2017 for whom a minimum of 6 months of follow-up was available.
Age in the registry: - to 14 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Novartis Pharmaceuticals Coordinator of this site? Confirm its status | East Hanover | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.